Daniel Grushkin

Threat to global GM soybean access as patent nears expiry (Nature Biotech)

image

This October, five major seed companies came together to sign the first part of an agreement called the Generic Event Marketability and Access Agreement (GEMAA). Facilitated by the Biotechnology Industry Organization (BIO) of Washington, DC, and the American Seed Trade Association of Alexandria, Virginia, the accord is a legally binding contract that covers expirations of single-gene patents, and aims to ensure global access to genetically modified (GM) crops, even once they go off patent.